Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thymic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00387868
What this trial is testing

Preoperative Treatment of Patients With High Risk Thymoma

Who this might be right for
Thymoma
Valley Health System 21
Testing effectiveness (Phase 2)Ended earlyNCT04925947
What this trial is testing

KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors

Who this might be right for
Thymic Carcinoma
Weill Medical College of Cornell University 4
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Not applicableStudy completedNCT03078699
What this trial is testing

Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity Assessment

Who this might be right for
ThymomaThymic Tumor
Third Military Medical University 32
Not applicableStudy completedNCT00965627
What this trial is testing

Biology of Thymic Tumors

Who this might be right for
Thymoma
Istituto Clinico Humanitas 134
Early research (Phase 1)Study completedNCT00066404
What this trial is testing

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

Who this might be right for
Cancer
Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Study completedNCT00921739
What this trial is testing

Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies

Who this might be right for
Non Small Cell Lung CancerSmall Cell Lung CancerThymoma+1 more
Duke University 24
Testing effectiveness (Phase 2)Study completedNCT04321330
What this trial is testing

Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma

Who this might be right for
Carcinoma, Thymic
Hoffmann-La Roche 34
Testing effectiveness (Phase 2)Study completedNCT00010257
What this trial is testing

Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma

Who this might be right for
ThymomaThymic Carcinoma
Eastern Cooperative Oncology Group 46
Testing effectiveness (Phase 2)UnknownNCT03466827
What this trial is testing

Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma

Who this might be right for
ThymomaAdvanced Thymic Epithelial Tumour
Morten Mau-Soerensen 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07479628
What this trial is testing

Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma

Who this might be right for
Thymic Carcinoma
Shanghai Chest Hospital 31
Testing effectiveness (Phase 2)Study completedNCT04710628
What this trial is testing

Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents

Who this might be right for
Metastatic Thymic CarcinomaThymoma Type B3
MedSIR 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT01025089
What this trial is testing

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

Who this might be right for
ThymomaThymic CarcinomaClinical Masaoka Stage II to IVA
Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)UnknownNCT03663764
What this trial is testing

Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor

Who this might be right for
Thymoma and Thymic Carcinoma
Sun Yat-sen University 57
Testing effectiveness (Phase 2)UnknownNCT03921671
What this trial is testing

Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT)

Who this might be right for
Thymic CarcinomaThymoma
Claudia Proto 60
Not applicableLooking for participantsNCT06523582
What this trial is testing

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Who this might be right for
Neuroendocrine NeoplasmNeuroendocrine Neoplasm of Gastrointestinal TractNeuroendocrine Neoplasm of Lung+23 more
Universidad Nacional Autonoma de Mexico 750
Testing effectiveness (Phase 2)Ended earlyNCT00818090
What this trial is testing

Paclitaxel and Cisplatin for Thymic Neoplasm

Who this might be right for
ThymomaThymic Carcinoma
Korean Cancer Study Group 39
Testing effectiveness (Phase 2)Looking for participantsNCT06980077
What this trial is testing

Ivonescimab for the Treatment of Thymic Cancer

Who this might be right for
Thymus Carcinoma
Jonsson Comprehensive Cancer Center 25
Not applicableLooking for participantsNCT06301945
What this trial is testing

Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors

Who this might be right for
Thymic Epithelial TumorThymic CarcinomaThymoma+1 more
Erasmus Medical Center 1,020
Testing effectiveness (Phase 2)Looking for participantsNCT05832827
What this trial is testing

First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)

Who this might be right for
Untreated Advanced or Recurrent Thymic Carcinomas
National Cancer Center, Japan 35
Next Page